StockpollyBeta
Get App
Popularity #1,694
VERX · NASDAQ · Software - Application

Vertex (VERX)

Automates indirect-tax determination, e-invoicing, returns, and reporting for global enterprises.

$11.50
After hours−0.22 (−1.92%)
At close$11.73(−0.55%)

  1. Vertex Posts Positive Phase II Data on Kidney Disease Drug

    Zacks Investment ResearchClinical

  2. Vertex Touts Encouraging Data From 'Underappreciated' Kidney Drug

    Benzinga

  3. Vertex Announces Positive Results From Phase 2b AMPLIFIED Study of Inaxaplin in Additional Populations of People With APOL1-Mediated Kidney Disease (AMKD) and Completion of Enrollment in the Phase 2/3 AMPLITUDE Trial

    Business Wire

  4. Vertex Pharmaceuticals Eyes Renal Growth With Key PDUFA, Pipeline Catalysts Ahead

    MarketBeat

  5. Vertex Pharmaceuticals Highlights Catalyst-Rich Pipeline Beyond Cystic Fibrosis

    MarketBeat

  6. Vertex Pharmaceuticals Maps Growth Beyond CF at Cantor Conference

    MarketBeat

  7. Strong Core Business, Raised Guidance Push Vertex Pharmaceuticals Higher

    FXEmpire

  8. Vertex, Inc. (VERX) Presents at Goldman Sachs Communacopia + Technology Conference 2026 Transcript

    Seeking AlphaEarnings

  9. Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

    Business WireM&A

  10. Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead

    The Motley FoolOther

  11. Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More

    The Motley Fool

  12. Vertex Pharmaceuticals: I Was Wrong About Its Near-Term Prospects (Rating Upgrade)

    Seeking Alpha

  13. Vertex Report: Rising Sales Tax Rates Signal a New Era of Tax Volatility

    GlobeNewsWire

  14. Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire?

    The Motley Fool

  15. 3 Reasons Why Growth Investors Shouldn't Overlook Vertex (VERX)

    Zacks Investment Research

  16. Why Vertex Pharmaceuticals Stock Ticked Higher on Tuesday

    The Motley Fool

  17. Vertex Analysts Lower Their Forecasts Following Q2 Results

    Benzinga

  18. Vertex Expands Leadership Team to Power the Next Chapter of Growth

    GlobeNewsWire

  19. Vertex Pharmaceuticals: A Transition Year Into A Multi-Franchise Growth Story

    Seeking Alpha

  20. Vertex, Inc. (VERX) Q2 2026 Earnings Call Transcript

    Seeking Alpha

  21. Vertex Q2 Earnings Call Highlights

    MarketBeat

  22. Vertex Pharmaceuticals Q2 Earnings Call Highlights

    MarketBeat

  23. Compared to Estimates, Vertex (VERX) Q2 Earnings: A Look at Key Metrics

    Zacks Investment Research

  24. Vertex (VERX) Q2 Earnings and Revenues Top Estimates

    Zacks Investment Research